Adverum Biotechnologies Q4 EPS $(0.23) Beats $(0.34) Estimate
Portfolio Pulse from Happy Mohamed
Adverum Biotechnologies reported a Q4 EPS loss of $0.23, surpassing the analyst consensus estimate of a $0.34 loss by 32.35%. This represents a 30.3% improvement over the $0.33 loss per share from the same period last year.
March 18, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adverum Biotechnologies reported a smaller than expected Q4 loss per share, indicating a positive trend in its financial performance.
The company's better-than-expected quarterly earnings report, showing a significant improvement over the previous year's losses, is likely to instill confidence among investors and could lead to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100